Cardiovascular MRI Aids Diastolic Heart Failure Diagnosis
By MedImaging International staff writers Posted on 20 Nov 2017 |
Image: According to research, cardiac MRi could soon replace hemodynamic assessments (Photo courtesy of Siemens Healthcare).
A new study will investigate whether diastolic heart failure (DHF) can be better diagnosed with the help of cardiovascular magnetic resonance imaging (CMRI).
Researchers at the German Centre for Cardiovascular Research (DZHK; Berlin, Germany) and University Hospital Frankfurt (Germany) are launching a multicenter study to establish CMRI as the standard method for diagnosing DHF, also known as heart failure with preserved ejection fraction (HFpEF). The study will compare CMR diagnostic data efficacy with that of the present gold standard, invasive hemodynamics, in which patients are examined using a cardiac catheter.
In order to obtain a more comprehensive picture of the diagnostic validity of CMR, the researchers will also compare CMR measurements to the results of ultrasound examinations and analyses of myocardial tissue samples. The data will also aid the researchers investigate whether CMR can help clarify why DHF disease arises, since unlike an ultrasound, CMR not only measures blood flow and ventricular filling, but can also identify an inflamed myocardium, pathological proliferation of the connective tissue, and change to small blood vessels.
“Only once the causes are clear can patients receive targeted medicinal therapy, because the treatment of myocardial inflammation differs entirely to that of a circulatory disorder. Therapeutic studies are only possible once we can distinguish between the various patient subgroups,” said lead researcher Professor Eike Nagel, MD, of University Hospital Frankfurt. “It is the first multicenter study on the diagnosis of HFpEF worldwide. Beside Frankfurt am Main, the DZHK sites in Berlin, Heidelberg, Göttingen, and Bad Nauheim are also participating. If the results are positive, the study would lead to a modification of the guidelines for diagnosing HFpEF.”
HFpEF is a complex disease, encompassing a diverse cohort of patients and marked by the presence of multiple etiological mechanisms. Diastolic dysfunction, in which the heart contracts properly, but cannot expand enough so that blood can fill the chamber, is considered a crucial component of the disease, which affects approximately 50% of patients with chronic heart failure (HF).
CMR is a medical imaging technology for the non-invasive assessment of the function and structure of the cardiovascular system that is based on the same basic principles as MRI, with optimizations that use rapid imaging sequences, requiring CMR images be acquired in steps. Patients breathe in and then hold their breath for each image, then recover before repeating the process for the next one.
Related Links:
German Centre for Cardiovascular Research
University Hospital Frankfurt
Researchers at the German Centre for Cardiovascular Research (DZHK; Berlin, Germany) and University Hospital Frankfurt (Germany) are launching a multicenter study to establish CMRI as the standard method for diagnosing DHF, also known as heart failure with preserved ejection fraction (HFpEF). The study will compare CMR diagnostic data efficacy with that of the present gold standard, invasive hemodynamics, in which patients are examined using a cardiac catheter.
In order to obtain a more comprehensive picture of the diagnostic validity of CMR, the researchers will also compare CMR measurements to the results of ultrasound examinations and analyses of myocardial tissue samples. The data will also aid the researchers investigate whether CMR can help clarify why DHF disease arises, since unlike an ultrasound, CMR not only measures blood flow and ventricular filling, but can also identify an inflamed myocardium, pathological proliferation of the connective tissue, and change to small blood vessels.
“Only once the causes are clear can patients receive targeted medicinal therapy, because the treatment of myocardial inflammation differs entirely to that of a circulatory disorder. Therapeutic studies are only possible once we can distinguish between the various patient subgroups,” said lead researcher Professor Eike Nagel, MD, of University Hospital Frankfurt. “It is the first multicenter study on the diagnosis of HFpEF worldwide. Beside Frankfurt am Main, the DZHK sites in Berlin, Heidelberg, Göttingen, and Bad Nauheim are also participating. If the results are positive, the study would lead to a modification of the guidelines for diagnosing HFpEF.”
HFpEF is a complex disease, encompassing a diverse cohort of patients and marked by the presence of multiple etiological mechanisms. Diastolic dysfunction, in which the heart contracts properly, but cannot expand enough so that blood can fill the chamber, is considered a crucial component of the disease, which affects approximately 50% of patients with chronic heart failure (HF).
CMR is a medical imaging technology for the non-invasive assessment of the function and structure of the cardiovascular system that is based on the same basic principles as MRI, with optimizations that use rapid imaging sequences, requiring CMR images be acquired in steps. Patients breathe in and then hold their breath for each image, then recover before repeating the process for the next one.
Related Links:
German Centre for Cardiovascular Research
University Hospital Frankfurt
Latest MRI News
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs